Determinants of HIV infection among pregnant women in Cameroon: A contribution toward the elimination of vertical transmission in low- and middle-income countries

Introduction

HIV infection is still prevalent in pregnant women and remains a major public health concern across several low-and middle-income countries (LMICs). Of note, about 1.5 million pregnant women are living with HIV worldwide (1,2), sub-Saharan Africa is home to two-third of cases worldwide (3), with prevalence varying between 5% and 42% among pregnant women (4).

Pregnant women living with HIV are at high risk of vertical transmission to their infants during pregnancy, childbirth or breastfeeding (5). Of relevance, in the absence of any intervention, between 20% and 45% of infants could contract HIV, with an estimated risk of 5-10% during pregnancy, 0-20% during labour and delivery and 5-20% during breastfeeding (4–9). Furthermore, without treatment, half of all HIV-infected children will die before their second birthday, thereby stressing the need to consider the elimination of HIV vertical in high priority countries, including Cameroon (4).

Despite a 50% decline in HIV prevalence from 5.5% in 2005 (10) to 2.7% in 2018 (11) in the general population, the burdens of HIV in specific populations including pregnant women remain high in Cameroon. Although HIV prevalence among pregnant women fell from 7.6% in 2009 to 4.26% in 2019 in Cameroon, some geographical regions still stand at higher risks (i.e. South with 8.46%), underscoring the need for regular surveillance to ensure evidence-based public health actions for eliminating HIV vertical transmission (12). Furthermore, HIV prevalence among pregnant women in Cameroon is similarly distributed, ranging from 5.58% in urban areas to 5.87% in rural settings according to reports of the sentinel surveillance survey of 2019 (13,14).

Several factors contribute to the dynamics of this infection in pregnant women in these Cameroonian settings, among which being single as marital status, multiparity, age and living in specific regions were significantly associated risk of contracting HIV infection (14). Thus, controlling these drivers of HIV infection among pregnant women is an essential component in achieving the global effort in eliminating paediatric HIV by 2030. However, with population dynamics and behavioural changes overtime, it is of paramount importance to generate update evidence for strategic information toward priority interventions at the public health level. Therefore, our study objective was to update HIV epidemiology and identify determinants of infection among pregnant women attending antenatal clinics in Cameroon.

Methods and materials

Data collection and HIV testing procedure

Two HIV tests were used according to national guidelines (national HIV screening algorithm): Determine (Abbott Laboratories, IL, USA) and Oraquick.

Data collection was carried out by health workers (Nurses and Midwives) in the antenatal and maternity consultation departments of the health facilities selected for the study. They were trained for 03 days in the use of Determine and Oraquick for HIV screening and in the study methodology. Testing took place at the entry point (antenatal and maternity clinics) of the health facilities selected for the study. The number of pregnant women to be recruited at each health facility was based on the average number of antepartum consultations per month. Pregnant women were recruited by voluntary sample until the size of the workforce per site was reached. When a pregnant women arrived at the ANC or maternity ward, the site’s trained provider introduced himself to her, checked her eligibility, sent her the information leaflet and asked for her informed consent.

Once the participants had provided informed consent, pre-test counselling was conducted, after which HIV testing of pregnant women was performed in accordance with the national algorithm (Figure 1). Pregnant women who tested positive by the national HIV screening algorithm were managed by the aforementioned health facility in accordance with the guidelines for HIV management in Cameroon.

• Download figure
• Open in new tab

Figure 1:

HIV screening algorithm used in the study

Results

Discussion

Evidence on HIV infection and its predictors among pregnant women is key to ensuring an HIV free new generation of children beyond 2030. Most importantly, LMICs like Cameroon require such epidemiological surveillance to set-up priority interventions with impact at country-level. In the present study, HIV seroprevalence among pregnant women was 2.6% IC95% [2.33; 2.93]. These results are similar to the last national HIV prevalence rate (2.7%) conducted in 2018 (11). Similarly, our findings are in close alignment with those of previous studies conducted in Burkina Faso (2.16%) and Mali (2.85%) (16,17). The present prevalence is significantly lower compared to the 2016 and 2019 sentinel surveys with 5.75% and 4.26% respectively among pregnant women (12,13), including the results of studies which reported HIV prevalences of 5.70% (95% CI: 4.93-6.40), 6% (3.0-10.2%) and 7.8% respectively among pregnant women in Cameroon (18–20). Furthermore, the respective prevalence rates of 9.2% and 7.22% reported in the countries of Chad and Nigeria are also of relevance (21,22). Our findings therefore reflect the declining trend of HIV among pregnant women in Cameroon (7.6% in 2009 to 2.9% in 2016 (19,23) and from 3.4% in 2018 to 2.1% in 2022 (24–26). This declining prevalence is the result of progress and strategies implemented by Cameroon in recent years to strengthen HIV prevention among women, who are disproportionately affected by HIV. These include the integration of reproductive health and maternal, newborn, child and adolescent health services/HIV/PMTCT, decentralisation of services and delegation of tasks, family-based HIV testing, implementation of option B+, contact tracing, implementation of Users Fees and HIV self-testing for partners of pregnant women (24).

The spatial distribution of HIV among pregnant women shows regional disparities varying from 2.2% in the Far North to 8.8% in the East and similarly low prevalence in the country major cities of Yaoundé (1.5%) and Douala (1.4%) (11). In similar surveys, regional variations from 0.7% in the Far North to 11.8% in the South, as well varying trends between urban and rural settings (14,19). These regional and urban disparities show that prevention activities and priority interventions achieved the expected goals more easily in the major cities, likely due to accessibility to several channels and means of information and communication. In addition, the educational level and the presence of community-based organisations in these major cities also contribute to strengthening HIV prevention, raising awareness and involving pregnant women and their partners in healthy behavioural factors. Henceforth, these results suggest strengthening strategies through targeted and differentiated priority HIV prevention interventions in regions, also supported by previous the Demographic and Health Survey (11).

Regarding drivers of HIV infection, single pregnant women were more likely to be infected with HIV than married or cohabiting women. These results are similar to previous reports (14,27), likely due to the fact that unmarried women are more likely to have several sexual partners thus increasing the risk of infection. Also, their economic vulnerability of most single women also exposes them to transactional sex (28). In this study, the risk of HIV infection increased with age. Indeed, pregnant women aged 30 and over were more likely to be infected with HIV than younger women. These results are comparable to those reported in the study by Anoubissi and al (14). These results are consistent with the distribution of HIV infection in the general population and suggest that younger women are better at implementing HIV prevention measures than older women. Lower level of education was significantly associated with a two-folds risk of acquiring HIV infection, as previously reported similarly reported in Cameroon and elsewhere (18,29). Thus, HIV prevention should prioritise women with low educational level, as they appear to poorly assimilate and implement HIV preventive measures. Gestational age, parity and history of abortion were significantly associated with HIV infection. Indeed, pregnant women in their 1^st or 2^nd trimester were almost 2 times more likely to be infected with HIV than those in their 3^rd trimester. Similarly, nulliparous, primiparous, pauciparous or multiparous pregnant women were almost 2 times more likely to be infected with HIV than large multiparous women. While suggesting further investigation on this area, Rindcy Davis et al showed that primiparous women were associated with a slightly lower prevalence of HIV testing (aPR 0.97, 95% CI 0.95, 0.99) than nulliparous women (30). Furthermore, pregnant women who had no abortions were 41% less likely to be infected with HIV than those who had had two or more abortions. Abortions generally traumatise and cause cervical and vaginal lesions, which probably increase the risk of contracting STIs, including HIV.

The potential limitations of this study would be the inability to detect cases of early infection, which would have been handled by performing nucleic acid testing or p24 antigen detection. However, this might have limited inference on the present evidence.

Conclusion

Despite the overall low-prevalence among pregnant women at national-level (2.6%), there are target population still experiencing higher risk of infection within the frame of an ongoing pregnancy, which include the absence or low-level of education, being elderly (>30 years), singleness, history of abortion and reporting low parity during ANC. Thus, public-health interventions towards these at-risk target groups will further limit events of new HIV infections among pregnant women, hence contributing to achieve eMTCT in Cameroon and other LMICs sharing similar epidemiological and programmatic features.